Clover (ASX:CLV) share price falls 10% on FY20 results

The Clover (ASX: CLV) share price has plummeted 10% in early morning trade following the release of its FY20 results. We take a closer look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Clover Corporation Limited (ASX: CLV) share price has plummeted 10.33% in early morning trade following the release of its FY20 results. The Clover share price reached as low as $2.13, before pushing back to $2.17 at the time of writing. 

Let's take a look at Clover's results for the financial year.

How did Clover perform in FY2020?

Clover reported a decent FY20 result underpinned by new products delivering growth in new segments and countries.

For the full year ending 31 July, Clover announced a revenue increase of $88.3 million, up 15% over FY 2019.  This was driven by improved demand across all key regions, particularly in Europe.

Earnings before interest, tax, depreciation and amortisation (EBITDA) came in at $18.9 million, an increase of 35% from $14 million in the prior period.

Net profit after tax stood at $12.5 million, an increase of 23.6% compared to $10.1 million the year before.

Earnings per share also increased to 7.51 cents, compared to 6.12 cents.

Clover revealed an operating expense of $11.4 million from investment in research and development programs to deliver future growth. This was a jump from the $10.3 million spent in FY2019.

Inventory leapt to $31.9 million, up from $4.2 million.

Clover advised its balance sheet is strong with $9.2 million cash on hand and a net debt of just $5.4 million.

The infant formula company declared a final dividend of 2.5 cents per share to be paid to shareholders on 18 November.

COVID-19 impact

Clover said that its FY20 result had been positively impacted by COVID-19 with increased demand through Q3 and Q4. This was due to its customers supplying additional infant formula to retail channels depleted by pantry stocking.

The company did advise, however, that new customer development had been curtailed due to the imposed travel restrictions. This affected its ability to perform audits, and attend trade shows.

Demand in the United States from new business development had been constrained as the company focused on other activities. Clover resourced its overseas team to service new and existing customers.

FY 2021 outlook

Due to the uncertainty of COVID-19, the company did not provide a guidance for 1HFY21. However, Clover mentioned that the pantry stocking from consumers could support strong sales in the first half of the year.

In addition, the company will seek to target new customers in Europe to meet the new IF standards and establish online or third-party audits.

Clover will also look to restart new product development in the United States, and increase supply chain vertical integration.

About the Clover share price

The Clover share price has made a strong comeback of 63% since falling as low as $1.33 in March. For the calendar year to date, the Clover share price is down 17.49% and has also fallen 34.44% from its 52-week high.

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Clover Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A young well-dressed couple at a luxury resort celebrate successful life choices.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors kept up the selling this session.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Morgans says these ASX 200 shares can rise 20%+

The broker says these shares could offer major upside.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Broker Notes

Brokers rate 2 ASX All Ords rippers of 2025: Is their phenomenal run over?

Both of these ASX shares more than tripled in value last year.

Read more »

a woman puts her hand to her chin and looks to the side deep in thought as though pondering something significant.
Broker Notes

2 ASX 200 gold shares to buy and 1 to sell: experts

After exceptional share price growth for 2 years, experts say investors need to choose their gold stocks carefully.

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why 4DMedical, ARB, Inghams, and Qoria shares are tumbling today

These shares are under pressure on Tuesday. What's going on?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Market News

Why Bellevue Gold, DroneShield, Hub24, and Telix shares are storming higher today

These shares are rising on Tuesday despite the market weakness.

Read more »

Keyboard button with the word sell on it, symbolising the time being right to sell ASX stocks.
Resources Shares

ASX 200 materials was the best sector of 2025 but it's time to sell these 3 shares: broker

Morgan Stanley has just updated its ratings and 12-month price targets on 3 ASX 200 mining shares.

Read more »

A red heart-shaped balloon float up above the plain white ones, indicating the best shares
Dividend Investing

Why this could be the best ASX dividend stock to buy today

There are few ideas that match this option for dividend investors.

Read more »